BIO-key International
BKYI
10 hedge funds and large institutions have $265K invested in BIO-key International in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
675% more capital invested
Capital invested by funds: $34.2K → $265K (+$231K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more funds holding
Funds holding: 8 → 10 (+2)
1.28% more ownership
Funds ownership: 0.12% → 1.4% (+1.3%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$360K |
| 2 |
VF
Virtu Financial
New York
|
+$21.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.55K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$58 |
| 5 |
HT
Headlands Technologies
Chicago,
Illinois
|
+$29 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$19.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.02K |
| 3 |
AFWM
Abich Financial Wealth Management
Ashburn,
Virginia
|
-$61 |
| 4 |
JP Morgan Chase
New York
|
-$29 |
BKYI Hedge Fund Activity: Q3 2024 in Review
10 of the 6,976 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2024, worth a combined $265K — up 675% from $34.2K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BKYI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $360K. The largest seller was Geode Capital Management, exiting entirely with an estimated $19.9K sold.
- 10 institutional investors held BIO-key International (BKYI) as of Q3 2024, up from 8 in Q2 2024.
- Funds reported $265K of BIO-key International stock for Q3 2024, up 675% quarter-over-quarter.
- 4 funds opened new BIO-key International positions in Q3 2024 and 2 closed out, a net change of +2 holders.
- The largest BIO-key International buyer in Q3 2024 was Armistice Capital, an estimated $360K added.
- The largest BIO-key International seller in Q3 2024 was Geode Capital Management, an estimated $19.9K sold.
Based on aggregated 13F filings for Q3 2024.